Anbio Biotechnology Class A Ordinary Shares (NNNN) vs Pro-Dex, Inc. (PDEX)

A side-by-side comparison of Anbio Biotechnology Class A Ordinary Shares and Pro-Dex, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NNNN vs PDEX

growth of $100 · dividends reinvested · last 2y
NNNN -16.3% (-8.5%/yr)PDEX +80.8% (+34.5%/yr)PDEX compounded faster over this window
200400600800Start $1002026$84$181
NNNN PDEX

NNNN vs PDEX: by the numbers

  • •NNNN is the larger company ($210M vs $209M market cap).
  • •NNNN converts more revenue to profit (74.06% vs 17.62% net margin).

Metrics side by side

Valuation

MetricNNNNPDEX
P/E ratioN/A15.86
Forward P/EN/A21.15
PEG ratioN/A0.54
P/S ratioN/A2.69
P/B ratio6.974.38
EV / EBITDAN/A15.19
FCF yieldN/A3.30%

Profitability

MetricNNNNPDEX
Gross margin87.24%31.38%
Operating margin66.70%16.75%
Net margin74.06%17.62%
ROE21.24%28.68%
ROIC19.13%14.99%

Growth (annualized)

MetricNNNNPDEX
Revenue CAGR (5Y)N/A15.32%
EPS CAGR (5Y)N/A29.38%
Total return CAGR (5Y)N/A20.45%

Frequently asked

Is NNNN or PDEX more profitable?
NNNN runs the higher net margin — NNNN at 74.06% versus PDEX at 17.62%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.